Media Releases Archives

Early Detection

Our proprietary miRNA technology detects cancer at its earliest, most treatable stages. With minimally invasive test and accurate insights, our tests enable patients to act sooner.

GASTROClear

A pioneering blood test for the early detection of gastric (stomach) cancer.

LUNGClear

A minimally invasive blood test designed to identify lung cancer at an early stage.

Therapy Selection

We leverage advanced Next-Generation Sequencing (NGS) technology to empower patients in personalised cancer treatment selection.

APEX Tissue

A Targeted 58-Gene Profiling Test

COMPASS Tissue

A Comprehensive 1021-Gene Profiling Test

Mirxes and NCCS Launch First-Of-Its-Kind Blood Test For Early Liver Cirrhosis To Advance Cancer & Failure Prevention

October 16, 2026

Mirxes and NCCS Launch CIRRHOClear™: A Breakthrough Blood Test for Early LiverCirrhosis Risk Stratification CIRRHOClear™ leverages intellectual property jointly owned by Mirxes and NCCS,developed from the landmark liver study, ELEGANCE1.

Media Release Category: Media Releases

Mirxes and NCCS Launch First-Of-Its-Kind Blood Test For Early Liver Cirrhosis To Advance Cancer & Failure Prevention